MIRA INFORM REPORT

 

 

Report Date :

29.05.2013

 

IDENTIFICATION DETAILS

 

Name :

MASTERASIA MARKETING COMPANY LTD.

 

 

Registered Office :

9F., No.189, Gangqian Rd., Neihu District, Taipei City 11494

 

 

Country :

Taiwan

 

 

Date of Incorporation :

23.08.1989

 

 

Com. Reg. No.:

23443294

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Trading of medical raw materials and etc.

 

 

No. of Employees :

About 40 Employees

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Taiwan

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

TAIWAN - ECONOMIC OVERVIEW

 

Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. In 2009, Taiwan's GDP contracted 1.8%, due primarily to a 13.1% year-on-year decline in exports. In 2010 GDP grew 10.7%, as exports returned to the level of previous years, and in 2011, grew 4.0%. In 2012, however, growth fell to 1.3%, because of softening global demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are major long-term challenges. Free trade agreements have proliferated in East Asia over the past several years, but except for the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, so far Taiwan has been excluded from this greater economic integration in part because of its diplomatic status. Negotiations continue on such follow-on components of ECFA regarding trade in goods and services. The MA administration has said that the ECFA will serve as a stepping stone toward trade pacts with other key trade partners, which Taiwan subsequently launched with Singapore and New Zealand. Taiwan's Total Fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 accounting for 11.2% of the island's total population as of 2012. The island runs a large trade surplus largely because of its surplus with China, and its foreign reserves are the world's fifth largest, behind China, Japan, Saudi Arabia, and Russia. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Three financial memorandums of understanding, covering banking, securities, and insurance, took effect in mid-January 2010, opening the island to greater investments from the mainland's financial firms and institutional investors, and providing new opportunities for Taiwan financial firms to operate in China. In August 2012, Taiwan Central Bank signed a memorandum of understanding on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which could help develop Taiwan into a local RMB hub. Closer economic links with the mainland bring greater opportunities for the Taiwan economy, but also poses new challenges as the island becomes more economically dependent on China while political differences remain unresolved.

Source : CIA


Contact Points

 

Company Name:

Masterasia Marketing Company Ltd.

Supplied Name:

Masterasia Marketing Co Ltd.

Trading Address:

9F., No.189, Gangqian Rd., Neihu District, Taipei City 11494, Taiwan (R.O.C.

Supplied Address:

9F, No. 189, Gangqian Rd., Taipei, Taiwan 1494

Telephone Number:

+886-2-2659-8566

Fax Number:

+886-2-2658-8963

Notes: The exact name and address are as above.

 

Credit Summary

 

Credit Opinion:

Business connections are permissible.

 

Company Identification Details

 

Registered Name:

Masterasia Marketing Company Ltd.

Registered Address:

9F., No.189, Gangqian Rd., Neihu District, Taipei City 11494, Taiwan (R.O.C.

Date of Foundation:

1989-8-23

Registration Number:

23443294

Registry:

Taipei City Government

Registered Capital:

NTD 28,000,000 (USD 938,000)

(As of 2013.5, 1 NTD = 0.0335 USD)

Paid-up Capital:

NTD 28,000,000 (USD 938,000)

Legal Representatives:

Shunqin Huang

Legal Form:

Joint Stock Company

Principal Activities:

Trading of medical raw materials and etc.

Staff:

About 40 Employees

Listed at Stock Exchange:

No

Date of Last Annual Return:

2013-1-2

 

History

 

Subject was incorporated on 1989-8-23 with registered number 23443294 as Joint Stock Company in Taiwan.

 

Shareholders

(Unit: NTD)

Name

Subscription Shares

Shunqin Huang

305,455

Mingzhi Huang

1,985,455

 

The information above is that of subject’s major shareholders.

 

Subsidiaries & Branches

 

Subject did not introduce whether it has any subsidiaries or branches, from other source we can not obtain the relevant information, either.

 

Personnel Information

Core Management

 

Directors

1

Name

Shunqin Huang

Position

Board Chairman

2

Name

Hanxiao Shihuang

Position

Director

3

Name

Mingju huang

Position

Director

4

Name

Mingzhi Huang

Position

Supervisor

 

Personnel Structure

 

Total Employees

About 40 Employees

 

Operation Information

Offices & Factories

 

 

Headquarters

Add

9F., No.189, Gangqian Rd., Neihu District, Taipei City 11494, Taiwan (R.O.C.

 

Production Information

 

l  Subject is a trader of medical raw materials and etc without any production activities.

 

Purchase Information

 

l  The registered activities of subject:

Business Code

Details

--

Sales of daily provisions of groceries.

--

Sales of chemical materials and food additives.

--

Sales of soft drink, juice, dairy and cosmetics.

--

Publishing and agent of newspaper and magazine.

--

Manufacturing, processing and sales of food additives, plastic additives. (except for disposed products)

--

Sales of electronic components.

--

Trading business of importing and exporting for related above products.

--

Agent of domestic and overseas manufacturers’ bidding, marking prices and sales.

F108011

Wholesales of traditional Chinese medicine.

F108021

Wholesales of western medicine.

F208011

Retails of traditional Chinese medicine.

F208021

Retails of western medicine.

F102160

Wholesales of accessary food.

I104010

Consultation of nutrition.

ZZ99999

Besides licensed business, all other business items those are not banned or restricted.

 

l  It is introduced that subject purchase products both in domestic and overseas markets.

Sales Information

 

l  The subject is mainly engaged in sales of medical raw materials and etc.

l  It is introduced that subject’s selling territory is mainly in domestic market.

l  It is introduced that subject’s major customers are manufacturers of medicine, food and etc.

l  It is introduced that subject is selling products with many brands, such as “OptiMSM®”, “Meioligo®’, “BCM-95®” and “NeOpuntia”, etc.

 

Major Products

1

Herbs

2

Herb extracts

3

Nutrition

4

Vegetable and fruit powder

5

Fiber

6

Enzyme

7

Probiotic mushroom

8

Special supplement

9

Functional oil

 

Import and export right:

Import right

Yes

Export right

Yes

 

Settlements

 

Purchase

 

Domestic Purchase

Product

Payment Terms

Proportion

Medical raw materials and etc

COD, CBD and etc

100%

 

Foreign Purchase

Product

Payment Terms

Proportion

Medical raw materials and etc

CBD and etc

100%

 

Sales

Domestic Markets

Product

Sales Terms

Proportion

Medical raw materials and etc

COD, CBD and etc

100%

 

Export

Product

Sales Terms

Proportion

Medical raw materials and etc

CBD and etc

100%

 


Financial Information

Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.

Subject’s relevant staff Ms. Huang declined to disclose its financials citing the grounds of company’s confidentiality; from other source we can not obtain the relevant information, either.

 

Bankers

 

Subject declined to disclose its bank details; from other source we cannot obtain the relevant information, either.

 

Public Record

 

Mortgage

 

No chattel mortgage record of subject has been found within the recent 3 months.

 

Lawsuit

 

Up to date of reporting, no existing or latent litigation of the subject has been found.

 

 

Interview Details

 

Name

Ms. Huang

Notes: We contacted with the subject through the supplied telephone number +886-2-2659-8566, the related staff Ms. Huang introduced the name, address and operation information as we supplied. But she refused to cooperate with us for this investigation, although we released Lubrizol's name.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.74

UK Pound

1

Rs.84.17

Euro

1

Rs.72.02

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.